scispace - formally typeset
Y

Yu Hu

Researcher at Huazhong University of Science and Technology

Publications -  487
Citations -  34645

Yu Hu is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 37, co-authored 435 publications receiving 24865 citations. Previous affiliations of Yu Hu include Chinese Ministry of Education & Guangzhou Medical University.

Papers
More filters
Journal ArticleDOI

Secondary Hemophagocytic Lymphohistiocytosis With Epstein–Barr Virus-Associated Transformed Follicular Lymphoma: A Case Report and Literature Review

Huan Xu, +9 more
- 25 Jun 2021 - 
TL;DR: A 58-year-old male was admitted to the hospital due to lasting fever, progressive lymphadenopathy and bicytopenia, with a previously histological diagnosis of follicular lymphoma grade 3a with Epstein-Barr virus-encoded RNA positive one month ago.
Journal Article

Development of image capture and displacement measurement system in centrifuge modeling and its application

Yu Hu, +3 more
- 01 Jan 2010 - 
TL;DR: A kind of image capture and displacement measurement system in centrifuge modeling is developed based on the idea of store forward that has the advantages of high automation, high precision, less preliminary preparation and noninterference to the soil.
Journal ArticleDOI

A genetic analysis of 23 Chinese patients with hemophilia B

Qing-Yun Wang, +7 more
- 25 Apr 2016 - 
TL;DR: It is implied that non-homologous end joining and microhomology-mediated break-induced replication are the putative mechanisms for the deletions of the F9 gene.
Journal ArticleDOI

Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia

Haoyi Wang, +14 more
- 20 Oct 2022 - 
TL;DR: The role of HMGB1 in ITP, which may serve as a potential target for thrombocytopenia therapy, is revealed and it is indicated that 18β-GA has the potential to restore immune balance in ITB via inhibition ofHMGB1 signaling.
Journal ArticleDOI

Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: A systematic review and network meta-analysis

Yun Wang, +11 more
- 14 Dec 2022 - 
TL;DR: In this article , the efficacy and safety of different treatments in newly diagnosed adult primary immune thrombocytopenia were compared in a systematic review and network meta-analysis of randomized controlled trials.